265 related articles for article (PubMed ID: 21908529)
1. Legal challenge to India's patent laws threatens access to generic drugs, says charity.
Moszynski P
BMJ; 2011 Sep; 343():d5753. PubMed ID: 21908529
[No Abstract] [Full Text] [Related]
2. Changes to India's patent law may deny cheap drugs to millions.
Mudur G
BMJ; 2005 Mar; 330(7493):692. PubMed ID: 15790640
[No Abstract] [Full Text] [Related]
3. India's new patent laws may still hurt generic drug supplies.
Chatterjee P
Lancet; 2005 Apr 16-22; 365(9468):1378. PubMed ID: 15841559
[No Abstract] [Full Text] [Related]
4. Intellectual property. Challenges to India's pharmaceutical patent laws.
Sampat BN; Shadlen KC; Amin TM
Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
[No Abstract] [Full Text] [Related]
5. India's rejection of Novartis's patent is but a small step in the right direction.
Bhaumik S
BMJ; 2013 Apr; 346():f2412. PubMed ID: 23596223
[No Abstract] [Full Text] [Related]
6. India's patent laws under pressure.
Roderick P; Pollock AM
Lancet; 2012 Sep; 380(9846):e2-4. PubMed ID: 22988579
[No Abstract] [Full Text] [Related]
7. The production of generic drugs in India.
Love J
BMJ; 2011 Mar; 342():d1694. PubMed ID: 21427048
[No Abstract] [Full Text] [Related]
8. Novartis challenges India's drug patent laws in Supreme Court.
Billingsley M
BMJ; 2012 Feb; 344():e1279. PubMed ID: 22354594
[No Abstract] [Full Text] [Related]
9. India's new patent bill threatens generic industry.
Ahmad K
Lancet Infect Dis; 2005 May; 5(5):265. PubMed ID: 15889471
[No Abstract] [Full Text] [Related]
10. India: New patent law may restrict access to HIV/AIDS treatments.
Cruess G
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
[TBL] [Abstract][Full Text] [Related]
11. Indian generic drug production. Benefits of EU-India free trade agreement.
Ager B
BMJ; 2011 Apr; 342():d2439. PubMed ID: 21502277
[No Abstract] [Full Text] [Related]
12. Amendments to the Canadian Patent Act to address drug access: is help on the way?
Penner MD; Narayanan P
Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
[No Abstract] [Full Text] [Related]
13. Big Pharma vs India’s Patent Office.
Pharm Pat Anal; 2012 Nov; 1(5):529. PubMed ID: 24236921
[No Abstract] [Full Text] [Related]
14. India's patent case victory rattles Big Pharma.
Chatterjee P
Lancet; 2013 Apr; 381(9874):1263. PubMed ID: 23589911
[No Abstract] [Full Text] [Related]
15. Novartis faces growing pressure to drop patent case against Indian government.
Hargreaves S
BMJ; 2007 Feb; 334(7590):383. PubMed ID: 17322224
[No Abstract] [Full Text] [Related]
16. Taking TRIPS to India--Novartis, patent law, and access to medicines.
Mueller JM
N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
[No Abstract] [Full Text] [Related]
17. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
Halliburton M
Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
[TBL] [Abstract][Full Text] [Related]
18. Canada ordered to implement WTO ruling against "stockpiling" of generic drugs.
Elliott R
Can HIV AIDS Policy Law Rev; 2000; 5(4):27. PubMed ID: 11833161
[TBL] [Abstract][Full Text] [Related]
19. Campaigners urge India to resist pressure to change patent laws.
Kmietowicz Z
BMJ; 2015 Jun; 350():h3218. PubMed ID: 26066656
[No Abstract] [Full Text] [Related]
20. More than 200,000 people ask Novartis to drop its challenge on drug patent.
Hargreaves S
BMJ; 2007 Feb; 334(7587):226. PubMed ID: 17272544
[No Abstract] [Full Text] [Related]
[Next] [New Search]
